Index Fund Advisors Inc. Takes $620,000 Position in Equifax, Inc. $EFX

Key Points

• Index Fund Advisors Inc. acquired a new position in Equifax, Inc. worth approximately $620,000, purchasing 2,391 shares in the second quarter.
• Equifax reported quarterly earnings of $2.00 per share, exceeding estimates and showcasing a 7.4% year-over-year revenue increase to $1.54 billion.
• The company recently declared a quarterly dividend of $0.50 per share, resulting in an annualized dividend of $2.00 and a dividend yield of 0.9%.

Index Fund Advisors Inc. purchased a new stake in Equifax, Inc. (NYSE:EFX - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 2,391 shares of the credit services provider's stock, valued at approximately $620,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. N.E.W. Advisory Services LLC purchased a new position in shares of Equifax in the 1st quarter worth approximately $28,000. Ameritas Advisory Services LLC bought a new stake in Equifax in the second quarter worth $31,000. Zions Bancorporation National Association UT purchased a new position in Equifax during the first quarter worth $32,000. Adirondack Trust Co. bought a new position in Equifax during the second quarter valued at $59,000. Finally, Exchange Traded Concepts LLC raised its stake in shares of Equifax by 42.4% in the first quarter. Exchange Traded Concepts LLC now owns 272 shares of the credit services provider's stock valued at $66,000 after acquiring an additional 81 shares during the period. 96.20% of the stock is currently owned by hedge funds and other institutional investors.

Equifax Price Performance

Shares of EFX stock opened at $230.11 on Monday. Equifax, Inc. has a twelve month low of $199.98 and a twelve month high of $294.92. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.79. The stock has a fifty day simple moving average of $247.65 and a two-hundred day simple moving average of $251.24. The stock has a market capitalization of $28.49 billion, a price-to-earnings ratio of 45.03, a P/E/G ratio of 2.70 and a beta of 1.68.

Equifax (NYSE:EFX - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.08. Equifax had a return on equity of 18.89% and a net margin of 10.95%.The firm had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.51 billion. During the same period in the previous year, the company posted $1.82 earnings per share. The firm's quarterly revenue was up 7.4% on a year-over-year basis. Equifax has set its Q3 2025 guidance at 1.870-1.970 EPS. FY 2025 guidance at 7.330-7.630 EPS. On average, analysts predict that Equifax, Inc. will post 7.58 EPS for the current fiscal year.

Equifax Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd were paid a dividend of $0.50 per share. The ex-dividend date was Tuesday, September 2nd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.9%. Equifax's dividend payout ratio (DPR) is currently 39.14%.

Analyst Upgrades and Downgrades

EFX has been the subject of a number of recent analyst reports. BMO Capital Markets dropped their price target on shares of Equifax from $280.00 to $260.00 and set a "market perform" rating for the company in a research note on Wednesday, July 23rd. Stifel Nicolaus upped their target price on Equifax from $277.00 to $295.00 and gave the company a "buy" rating in a research note on Wednesday, June 18th. Morgan Stanley reiterated an "overweight" rating on shares of Equifax in a report on Friday, October 3rd. Barclays dropped their price objective on Equifax from $260.00 to $240.00 and set an "equal weight" rating for the company in a report on Wednesday, July 23rd. Finally, Weiss Ratings reiterated a "hold (c+)" rating on shares of Equifax in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $282.47.

Insider Activity

In related news, CEO Mark W. Begor sold 48,264 shares of Equifax stock in a transaction that occurred on Monday, July 28th. The shares were sold at an average price of $241.71, for a total transaction of $11,665,891.44. Following the transaction, the chief executive officer directly owned 142,872 shares of the company's stock, valued at $34,533,591.12. This trade represents a 25.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 1.40% of the company's stock.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.

Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.